Faberco Life Sciences, Inc

A sourcing, marketing and distribution company of Pharmaceutical products in the Philippines

[Faberco Life Sciences, Inc @fabercolife]

COVID-19 is not yet over. Stay safe always.

[Faberco Life Sciences, Inc @fabercolife]

An insightful response from our speaker, to one of the questions during the webinar COVID-19: Back on the Rise.

Watch out for more learning highlights that we will be sharing!

[Faberco Life Sciences, Inc @fabercolife]

Novavax on Twitter https://t.co/XTIwRpcwkT

[Faberco Life Sciences, Inc @fabercolife]

FAQs about Molnupiravir

[Faberco Life Sciences, Inc @fabercolife]

Here are some of the learning highlights from the webinar COVID-19: Back on the Rise held last August 26.
-Changes in Testing, Quarantine and Isolation
-How does Molnupiravir work?
Watch out for more learning highlights that we will be sharing!

[Faberco Life Sciences, Inc @fabercolife]

New Zealand grants provisional approval for Novavax’s Covid-19 as a heterologous and homologous booster dose in adults aged 18 years and above.

https://t.co/HcSqLDcAj9

[Faberco Life Sciences, Inc @fabercolife]

Public Advisory: If you are diagnosed with COVID-19 and you are prescribed Molnupiravir, make sure you are protected and only get those that are given Emergency Use Authorization (EUA) by the Philippine FDA.

[Faberco Life Sciences, Inc @fabercolife]

Get only EUA approved Molnupiravir!

[Faberco Life Sciences, Inc @fabercolife]

Be informed and stay safe!

[Faberco Life Sciences, Inc @fabercolife]

Guidelines for Patients, Parents and Caregivers Emergency Use Authorization (EUA) of Molnupiravir Capsules 200 mg (Molnarz™) for Coronavirus Disease 2019 (COVID-19)

https://t.co/UbG5yqaBwZ

[Faberco Life Sciences, Inc @fabercolife]

Faberco Life Sciences, Inc. (FLSI) announced that the use of COVOVAX™ in children and adolescents 12 to less than 18 years old has been approved by the Philippine Food and Drug Administration on June 30, 2022. COVOVAX™ is now indicated for use in ages 12 years and older.

[Faberco Life Sciences, Inc @fabercolife]

For questions about Molnupiravir, we are here to assist.

[Faberco Life Sciences, Inc @fabercolife]

Is it ok to stop Molnupiravir after 2 days of intake if the patient is feeling better, or do you need to finish the 5 days cycle?

[Faberco Life Sciences, Inc @fabercolife]

FABERCO FILES FOR AN AMENDMENT OF COVOVAX EUA TO INCLUDE PEDIATRIC EXPANSION IN ADOLESCENTS (12 TO 17 YEARS OLD)

[Faberco Life Sciences, Inc @fabercolife]

Updated List of Hospitals with Molnupiravir (MOLNARZ)
National Capital Region

[Faberco Life Sciences, Inc @fabercolife]

Updated List of Hospitals with Molnupiravir (MOLNARZ)
NCR, Region 1 (Ilocos Region) and 3 (Central Luzon)

[Faberco Life Sciences, Inc @fabercolife]

Updated List of Hospitals with Molnupiravir (MOLNARZ)
Region 4-A (CALABARZON)

[Faberco Life Sciences, Inc @fabercolife]

Updated List of Hospitals with Molnupiravir (MOLNARZ)

Region 6 (Western Visayas), Region 9 (Zamboanga Peninsula)

[Faberco Life Sciences, Inc @fabercolife]

Happening tomorrow, January 28, 2022 at 5:30PM 
UPDATES ON COVID-19 TREATMENT AND THE ROLE OF MOLNUPIRAVIR WEBINAR.

[Faberco Life Sciences, Inc @fabercolife]

List of Hospitals with Molnupiravir (Molnarz™) updated as of January 25, 2022.
Molnarz™ is a Molnupiravir brand granted Emergency Use Authorization (EUA) by the Philippine Food and Drug Administration (FDA).